Chugai Pharmaceutical Co. Ltd. logo

Chugai Pharmaceutical Co. Ltd.

CHGCY | OTC
Chart Builder DCF Calculator
$21.01
-$0.45 (-2.10%)
Sep 24, 2026, 10:00 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
434.01B 387.32B 325.47B 575.88B 470.37B 340.23B
Depreciation & Amortization
32.54B 31.67B 31.74B 31.43B 30.87B 30.48B
Stock-Based Compensation
n/a 383M n/a n/a n/a n/a
Other Working Capital
-79.65B -28.84B 130.63B -183.31B -83.12B -64.42B
Other Non-Cash Items
2.56B 57.08B -77.92B -179.89B -138.49B -101.25B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-79.65B -28.84B 130.63B -183.31B -83.12B -64.42B
Operating Cash Flow
389.45B 447.6B 409.93B 244.11B 279.63B 205.04B
Capital Expenditures
-76.27B -50.93B -74.26B -71.24B -72.87B -61.41B
Cash Acquisitions
7.51B n/a n/a 1.05B 6.9B 4.35B
Purchase of Investments
-1.23T -948.55B -545.98B -519B -372.26B -248.32B
Sales Maturities Of Investments
1.13T 771.02B 546.96B 442.92B 325.03B 211.32B
Other Investing Acitivies
29M 1.1B 33.68B 280M -5.72B -4.25B
Investing Cash Flow
-204.87B -227.37B -37.29B -145.99B -118.93B -98.31B
Debt Repayment
n/a -8.15B n/a n/a n/a n/a
Common Stock Repurchased
-6M -10M -5M -5M -8M -30M
Dividend Paid
-299.42B -133.25B -131.59B -138.22B -98.64B -91.44B
Other Financial Acitivies
-8.17B 401M -7.95B -7.66B -9.08B -8.47B
Financial Cash Flow
-307.46B -141.01B -139.33B -145.64B -107.41B -99.5B
Net Cash Flow
-113.6B 81.53B 236.51B -45.58B 55.42B 8.39B
Free Cash Flow
313.18B 396.68B 335.67B 172.87B 206.76B 143.62B
Adj. Free Cash Flow
313.18B 396.29B 335.67B 172.87B 206.76B 143.62B
Maintenance CapEx
-44.53B -29.49B -74.26B n/a n/a -26.29B
Growth CapEx
-31.74B -21.44B n/a -71.24B -72.87B -35.12B
Owner Earnings
344.92B 418.11B 335.67B 244.11B 279.63B 178.74B

© 2026 bestshares.com. All rights reserved.